Bifidobacterium bifidum G9‐1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open‐Label, Randomized Controlled Trial (Binary STAR Study)

Documenti analoghi

• Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity‐score‐matched retrospective cohort study
  di: Junya Hironaka, et al.
  Pubblicazione: (2024)
• Low‐carbohydrate diets in East Asians with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials
  di: Junya Hironaka, et al.
  Pubblicazione: (2024)
• Maximum insulin dose in patients admitted to the intensive care units with severe COVID‐19 in the “Cross ICU Searchable Information System” study: A multicenter retrospective cohort study
  di: Emi Ushigome, et al.
  Pubblicazione: (2024)
• Age‐Stratified Associations of Sarcopenic Obesity With Mortality in Type 2 Diabetes
  di: Shinta Yamamoto, et al.
  Pubblicazione: (2026)
• A multi‐omics approach to overeating and inactivity‐induced muscle atrophy in db/db mice
  di: Takuro Okamura, et al.
  Pubblicazione: (2024)